A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus

by Fabián E. Díaz, Mariana Guerra-Maupome, Paiton O. McDonald, Daniela Rivera-Pérez, Alexis M. Kalergis, Alexis M. Kalergis, Jodi L. McGill
Published 2021-04-01

Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus

by Orlando A. Acevedo, Fabián E. Díaz, Tomas E. Beals, Felipe M. Benavente, Jorge A. Soto, Jorge Escobar-Vera, Pablo A. González, Alexis M. Kalergis, Alexis M. Kalergis
Published 2019-03-01

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus

by María José Altamirano-Lagos, Fabián E. Díaz, Miguel Andrés Mansilla, Daniela Rivera-Pérez, Daniel Soto, Jodi L. McGill, Abel E. Vasquez, Abel E. Vasquez, Alexis M. Kalergis, Alexis M. Kalergis
Published 2019-05-01

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design

by Camila Covián, Camila Covián, Ayleen Fernández-Fierro, Angello Retamal-Díaz, Fabián E. Díaz, Abel E. Vasquez, Abel E. Vasquez, Margarita K. Lay, Margarita K. Lay, Claudia A. Riedel, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis, Alexis M. Kalergis
Published 2019-11-01